The primarily evaluation of effect of fenofibrate in treatment of the lipid metabolism disorder
- Author:
Tan Cong Le
- Publication Type:Journal Article
- Keywords:
lipid
- MeSH:
Lipid Metabolism;
Procetofen;
therapeutics
- From:Journal of Practical Medicine
2002;435(11):38-40
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
33 patients ages of 38-78 in the hospital 175 participated to a study during 1/1998 5/1999. The research found that fenofibrate (lipanthy) at dose of 300 mg per day reduced obviously the total cholesterol, low density lipoprotein cholesterol and triglyceride. The more high level of these, the more effect of the drug was well tolerated and high safety. The side effects were mild and uncommon. The ure, creatinine, transaminase values were not changed by the drug and there were no complication of the gallblader stone
